Company Filing History:
Years Active: 2020-2022
Title: The Innovations of Dean Ng
Introduction
Dean Ng is a prominent inventor based in San Francisco, California. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules for hepatitis B virus. With a total of four patents to his name, Ng's work has the potential to impact therapeutic approaches for viral infections.
Latest Patents
Ng's latest patents include groundbreaking innovations such as "Multi-valent hepatitis B virus antigen binding molecules and uses thereof." This patent describes a multimeric hepatitis B virus protein binding molecule, which comprises at least two bivalent binding units. These units are associated with an HBV antigen binding domain, providing a novel approach to targeting the virus. Another significant patent is "Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function." This patent outlines modified human IgM heavy chain constant regions that exhibit reduced complement-dependent cytotoxicity, offering new avenues for therapeutic development.
Career Highlights
Ng is currently employed at Igm Biosciences, Inc., where he continues to innovate in the field of immunology. His work focuses on creating advanced binding molecules that can enhance the efficacy of treatments for various diseases. His contributions have been recognized within the scientific community, and he is regarded as a leading figure in his area of expertise.
Collaborations
Ng collaborates with notable colleagues such as Ramesh Baliga and Bruce Alan Keyt. These partnerships enhance the research and development efforts at Igm Biosciences, Inc., fostering an environment of innovation and discovery.
Conclusion
Dean Ng's contributions to biotechnology through his patents and collaborations highlight his role as a key inventor in the field. His work on hepatitis B virus binding molecules represents a significant advancement in therapeutic strategies.